[
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2167b34c947a0bb961eb7917d3bbdcfd3a37409f03de1a45629378cfdc79b3ea",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734541620,
      "headline": "Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors",
      "id": 132158744,
      "image": "",
      "related": "ZBH",
      "source": "MarketWatch",
      "summary": "Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2167b34c947a0bb961eb7917d3bbdcfd3a37409f03de1a45629378cfdc79b3ea"
    }
  },
  {
    "ts": null,
    "headline": "NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...",
    "summary": "Despite a challenging quarter, NeuroOne Medical Technologies Corp (NMTC) anticipates robust revenue growth in 2025, driven by new FDA approvals and strategic alliances.",
    "url": "https://finnhub.io/api/news?id=d2d7156f8a69528467a2a7e4a1f5063ba820c6fc2eb555e59be4a4be46683594",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734541229,
      "headline": "NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...",
      "id": 132041129,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/f90cc90b138c640893550fa4830f9628",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Despite a challenging quarter, NeuroOne Medical Technologies Corp (NMTC) anticipates robust revenue growth in 2025, driven by new FDA approvals and strategic alliances.",
      "url": "https://finnhub.io/api/news?id=d2d7156f8a69528467a2a7e4a1f5063ba820c6fc2eb555e59be4a4be46683594"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago",
    "summary": "Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...",
    "url": "https://finnhub.io/api/news?id=2cd672269ce03cce75ea7460a72bfcc9349d5e04de1e8d04257d92396d196f06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734530123,
      "headline": "Zimmer Biomet Holdings (NYSE:ZBH) shareholders have endured a 23% loss from investing in the stock five years ago",
      "id": 132041130,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...",
      "url": "https://finnhub.io/api/news?id=2cd672269ce03cce75ea7460a72bfcc9349d5e04de1e8d04257d92396d196f06"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31, 2025 to stockholders of record as of the close of business on December 30, 2024.",
    "url": "https://finnhub.io/api/news?id=69c5df7cd431f6965056b831af660d6c9f9f7e09a13eecd6720b3a9f131a59dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734523200,
      "headline": "Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024",
      "id": 132041131,
      "image": "https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2024. The cash dividend of $0.24 per share is payable on or about January 31, 2025 to stockholders of record as of the close of business on December 30, 2024.",
      "url": "https://finnhub.io/api/news?id=69c5df7cd431f6965056b831af660d6c9f9f7e09a13eecd6720b3a9f131a59dc"
    }
  },
  {
    "ts": null,
    "headline": "Q4 2024 Neuroone Medical Technologies Corp Earnings Call",
    "summary": "Q4 2024 Neuroone Medical Technologies Corp Earnings Call",
    "url": "https://finnhub.io/api/news?id=b3b4f4ceb221c6d60b6cc1c3de8aa6b07b36d94881530ad1cecd7f2fac9d1b61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734505754,
      "headline": "Q4 2024 Neuroone Medical Technologies Corp Earnings Call",
      "id": 132041132,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Q4 2024 Neuroone Medical Technologies Corp Earnings Call",
      "url": "https://finnhub.io/api/news?id=b3b4f4ceb221c6d60b6cc1c3de8aa6b07b36d94881530ad1cecd7f2fac9d1b61"
    }
  }
]